2064 related articles for article (PubMed ID: 8348562)
1. Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors.
Eisenthal A; Skornick Y; Merimsky O; Hirsch R; Zakut V; Ron I; Chaitchik S
Cancer Immunol Immunother; 1993 Sep; 37(4):233-9. PubMed ID: 8348562
[TBL] [Abstract][Full Text] [Related]
2. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant.
Aruga A; Aruga E; Chang AE
Cancer Res; 1997 Aug; 57(15):3230-7. PubMed ID: 9242454
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.
Kircheis R; Küpcü Z; Wallner G; Rössler V; Schweighoffer T; Wagner E
Cancer Gene Ther; 2000 Jun; 7(6):870-8. PubMed ID: 10880017
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
[TBL] [Abstract][Full Text] [Related]
5. The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.
Labarthe MC; Halanek N; Birchall L; Russell N; Desel C; Todryk S; Peters MJ; Lucas A; Falkenberg FW; Dalgleish AG; Whelan M; Ward SJ
Cancer Immunol Immunother; 2006 Mar; 55(3):277-88. PubMed ID: 16158275
[TBL] [Abstract][Full Text] [Related]
6. Immunization with interleukin-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens prolongs the survival of mice with melanoma.
Kim TS; Russell SJ; Collins MK; Cohen EP
Int J Cancer; 1993 Nov; 55(5):865-72. PubMed ID: 8244584
[TBL] [Abstract][Full Text] [Related]
7. Effects of interleukin-6 on hematopoiesis in allogeneic and syngeneic bone marrow chimeras.
Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi M; Kobayashi S; Tanaka J; Kasai M; Sakurada K
Immunobiology; 1994 Aug; 191(1):21-37. PubMed ID: 7806257
[TBL] [Abstract][Full Text] [Related]
8. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
Staib L; Harel W; Mitchell MS
Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.
Melcher A; Todryk S; Bateman A; Chong H; Lemoine NR; Vile RG
Cancer Res; 1999 Jun; 59(12):2802-5. PubMed ID: 10383135
[TBL] [Abstract][Full Text] [Related]
10. Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice.
Givon T; Revel M; Slavin S
Blood; 1994 Mar; 83(6):1690-7. PubMed ID: 8123861
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor-based melanoma cell vaccines immunize syngeneic and allogeneic recipients via host dendritic cells.
Schneeberger A; Lührs P; Kutil R; Steinlein P; Schild H; Schmidt W; Stingl G
J Immunol; 2003 Nov; 171(10):5180-7. PubMed ID: 14607918
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.
Glick RP; Lichtor T; de Zoeten E; Deshmukh P; Cohen EP
Neurosurgery; 1999 Oct; 45(4):867-74. PubMed ID: 10515482
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
[TBL] [Abstract][Full Text] [Related]
14. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.
Harada M; Matsuzaki G; Shinomiya Y; Kurosawa S; Ito O; Okamoto T; Takenoyama M; Sumitika H; Nishimura Y; Nomoto K
Cancer Immunol Immunother; 1994 May; 38(5):332-8. PubMed ID: 8162615
[TBL] [Abstract][Full Text] [Related]
15. Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy.
Stagg J; Lejeune L; Paquin A; Galipeau J
Hum Gene Ther; 2004 Jun; 15(6):597-608. PubMed ID: 15212718
[TBL] [Abstract][Full Text] [Related]
16. [Effect of exogenous RNA preparations on the antitumor activity of the splenocytes in C3HA mice].
Aksenova NN; Golosova IuV; Fel' VIa
Tsitologiia; 1984 Jun; 26(6):729-34. PubMed ID: 6084886
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
[TBL] [Abstract][Full Text] [Related]
18. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
[TBL] [Abstract][Full Text] [Related]
20. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
